-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on LifeStance Health Gr, Raises Price Target to $12

Benzinga·02/26/2026 18:23:50
Listen to the news
UBS analyst Kevin Caliendo maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $10 to $12.